StockData

TransMedics vs UFP Technologies

TMDX and UFPT side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How TMDX and UFPT compare

TransMedics is the larger company, worth 1.4 times as much as UFP Technologies ($3.3B against $2.3B).

On earnings, TransMedics is cheaper: it trades at 24.4× trailing earnings, against 32.1× for UFP Technologies.

TransMedics grew revenue faster over the last twelve months (25.8% versus 7.3% for UFP Technologies).

TransMedics keeps more of each dollar of sales as profit, with a net margin of 22.7% compared with 11.4% at UFP Technologies.

TransMedics scores higher on the StockData Score (14 against 13 for UFP Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricTMDXUFPT
Size and price
Market cap$3.3B$2.3B
Share price$93.91$297.49
Change, 1 year−18.3%28.5%
Change, 5 years329%329%
Beta (5Y)0.771.28
Employees8984,846
StockData Score
Total score14 (better)13
Valuation score5 (better)0
Growth score22
Performance score36 (better)
Health score45 (better)
Dividend score00
Valuation
P/E24.4× (better)32.1×
P/S4.9×3.6× (better)
P/B6.3×5.0× (better)
EV/EBITDA23.8× (better)25.0×
P/FCF41.2×–
PEG–1.88
FCF yield2.4%–
Fair value$131.38$241.18
Margin of safety28.5% (better)−23.3%
Growth
Revenue growth (TTM)25.8% (better)7.3%
Revenue growth, 5Y average88.2% (better)27.4%
Net income growth (TTM)112% (better)7.7%
EPS growth (TTM)99.5% (better)7.5%
EPS growth, 5Y average–37.7%
Profitability
Gross margin58.7% (better)28.5%
Operating margin12.2%15.3% (better)
Net margin22.7% (better)11.4%
FCF margin11.8%–
Return on equity36.3% (better)17.1%
Return on invested capital–14.2%
Financial health
Debt / equity0.04 (better)0.25
Net debt / EBITDA−3.841.12 (better)
Interest coverage3.8×12.4× (better)
Current ratio6.62 (better)3.00
Altman Z-score2.918.82 (better)
Piotroski F-score6 (better)5
Dividends and buybacks
Dividend yield0.00%–
Years of dividend growth0–
Shareholder yield0.00%0.00%
Ownership
Held by institutions100%123%
Held by insiders3.9%4.5%
Insider net buying, 12 months−$4.2M (better)−$13.6M
Short interest, % of float26.6%12.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.